What are Avalo Therapeutics's profit margins?

Avalo Therapeutics (AVTX) runs a 182.0% gross margin and a -15536.1% operating margin, with a -7965.8% net margin.

Where do Avalo Therapeutics's ratios come from?

Every ratio is computed from Avalo Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Avalo Therapeutics AVTX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-72.4%-22.4pp	-50.1%—	——	——
Liquidity
Current ratio	8.1×-11.8×	20×+18.1×	1.8×+1.1×	0.7×-2.4×
Leverage
Debt-to-equity	0×0.0×	0×-0.3×	0.3×—	——
Per Share
Book value per share	$6.20-65.1%	$17.75—	——	——
Valuation
Market capitalization	$954.59M+1,783%	$77.74M+966%	$7.29M-84.6%	$47.45M-75.2%
Price / book	13.8×+13.4×	0.6×-0.4×	1×—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Avalo Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Avalo Therapeutics's profit margins?: Avalo Therapeutics (AVTX) runs a 182.0% gross margin and a -15536.1% operating margin, with a -7965.8% net margin.
Where do Avalo Therapeutics's ratios come from?: Every ratio is computed from Avalo Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.